Meditera Tibbi Malzeme Sanayi ve Ticaret AS (MEDTR) — Capital Reinvestment Ratio
Meditera Tibbi Malzeme Sanayi ve Ticaret AS (MEDTR) has a Capital Reinvestment Ratio of 0.13x as of March 2026, meaning it reinvests 0% of its operating cash flow (TL180.45 Million) in capital expenditures (TL24.08 Million). See Meditera Tibbi Malzeme Sanayi ve Ticaret (MEDTR) FCF generation index to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Meditera Tibbi Malzeme Sanayi ve Ticaret AS Capital Reinvestment Ratio (2020–2025)
This chart tracks Meditera Tibbi Malzeme Sanayi ve Ticaret AS's Capital Reinvestment Ratio across 6 annual periods.
Annual Capital Reinvestment Ratio for Meditera Tibbi Malzeme Sanayi ve Ticaret AS (2020–2025)
Year-by-year Capital Reinvestment Ratio for Meditera Tibbi Malzeme Sanayi ve Ticaret AS from 2020 to 2025. For live market cap and broader valuation context, see how much is Meditera Tibbi Malzeme Sanayi ve Ticaret worth.
| Year | Reinvestment Ratio | Operating CF (TRY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.44x | TL435.35 Million | TL191.67 Million | ▲ +30.4% |
| 2024 | 0.34x | TL780.69 Million | TL263.52 Million | ▼ -9.8% |
| 2023 | 0.37x | TL801.02 Million | TL299.70 Million | ▼ -96.3% |
| 2022 | 10.07x | TL5.10 Million | TL51.35 Million | ▲ +4036.4% |
| 2021 | 0.24x | TL36.64 Million | TL8.92 Million | ▼ -14.5% |
| 2020 | 0.28x | TL73.26 Million | TL20.85 Million | — |